Dimensional Fund Advisors’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.57M Sell
1,234,870
-406,658
-25% -$765K ﹤0.01% 2754
2025
Q4
$3.92M Sell
1,641,528
-272,568
-14% -$745K ﹤0.01% 2594
2025
Q3
$5.46M Sell
1,914,096
-68,841
-3% -$236K ﹤0.01% 2522
2025
Q2
$7.48M Buy
1,982,937
+145,921
+8% +$574K ﹤0.01% 2387
2025
Q1
$8.32M Buy
1,837,016
+245,451
+15% +$1.3M ﹤0.01% 2322
2024
Q4
$11.3M Buy
1,591,565
+235,686
+17% +$1.88M ﹤0.01% 2264
2024
Q3
$11M Sell
1,355,879
-44,558
-3% -$322K ﹤0.01% 2264
2024
Q2
$8.95M Sell
1,400,437
-228,756
-14% -$1.47M ﹤0.01% 2312
2024
Q1
$12.3M Buy
1,629,193
+82,261
+5% +$751K ﹤0.01% 2216
2023
Q4
$14.3M Buy
1,546,932
+66,613
+4% +$544K ﹤0.01% 2150
2023
Q3
$15M Buy
1,480,319
+275,695
+23% +$3.29M ﹤0.01% 2070
2023
Q2
$15.1M Buy
1,204,624
+428,942
+55% +$5.11M ﹤0.01% 2065
2023
Q1
$9.05M Buy
775,682
+452,460
+140% +$5.77M ﹤0.01% 2273
2022
Q4
$3.44K Buy
323,222
+186,724
+137% +$1.8M ﹤0.01% 2557
2022
Q3
$1.32M Sell
136,498
-229,806
-63% -$3.04M ﹤0.01% 2818
2022
Q2
$5.31M Sell
366,304
-104,169
-22% -$1.78M ﹤0.01% 2428
2022
Q1
$12.3M Buy
470,473
+64,232
+16% +$1.82M ﹤0.01% 2200
2021
Q4
$16.1M Buy
406,241
+119,481
+42% +$5.45M ﹤0.01% 2106
2021
Q3
$14.3M Sell
286,760
-4,273
-1% -$233K ﹤0.01% 2165
2021
Q2
$16.2M Buy
291,033
+65,158
+29% +$3.47M 0.01% 2147
2021
Q1
$10.6M Buy
225,875
+187,617
+490% +$9.09M ﹤0.01% 2304
2020
Q4
$1.67M Buy
+38,258
New +$1.41M ﹤0.01% 2854

Other funds holding HCAT

Dimensional Fund Advisors's HCAT Position: Q1 2026 in Review

Dimensional Fund Advisors reduced its Health Catalyst (HCAT) stake by 25% in Q1 2026, selling an estimated $765K and leaving 1,234,870 shares worth $1.57M. The position accounts for ﹤0.01% of the portfolio, ranked #2754.

Dimensional Fund Advisors first reported a position in HCAT in Q4 2020 and has held it in 22 quarters since. The position peaked at $16.2M in Q2 2021. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Dimensional Fund Advisors held 1,234,870 shares of Health Catalyst worth $1.57M as of Q1 2026.
  • Dimensional Fund Advisors sold 406,658 Health Catalyst shares in Q1 2026, an estimated $765K.
  • Health Catalyst made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2754 holding.
  • Dimensional Fund Advisors first reported a position in Health Catalyst in Q4 2020 and has held it in 22 quarters since.
  • Dimensional Fund Advisors's Health Catalyst position peaked at $16.2M in Q2 2021.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.